Quantitative exposure assessment: application of physiologically-based pharmacokinetic (PBPK) modeling of low-dose, long-term exposures of organic acid toxicant in the brain

By Kim C.S.   Sandberg J.A.   Slikker W.   Binienda Z.   Schlosser P.M.   Patterson T.A.  

Environmental Toxicology and Pharmacology, Vol. 9, Iss. 4, 2001-03 ,pp. : 153-160

Elsevier

Access to resources Recommend Favorite

Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 4, 2015-04 ,pp. : 226-230

John Wiley & Sons Inc

Access to resources Recommend Favorite

Physiologically-based pharmacokinetic modeling of pyrene in the rat

By Haddad S.   Withey J.   Lapare S.   Law F.   Krishnan K.  

Environmental Toxicology and Pharmacology, Vol. 5, Iss. 4, 1998-06 ,pp. : 245-255

Elsevier

Access to resources Recommend Favorite

The use of in vitro metabolic parameters and physiologically based pharmacokinetic (PBPK) modeling to explore the risk assessment of trichloroethylene

By Hissink E.M.   Bogaards J.J.P.   Freidig A.P.   Commandeur J.N.M.   Vermeulen N.P.E.   van Bladeren P.J.  

Environmental Toxicology and Pharmacology, Vol. 11, Iss. 3, 2002-07 ,pp. : 259-271

Elsevier

Access to resources Recommend Favorite

A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines

By Tegenge Million   Mitkus Robert  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 40, Iss. 5, 2013-10 ,pp. : 545-556

Springer Publishing Company

Access to resources Recommend Favorite